SU2C Genomics-Enabled Medicine for Melanoma (GEMM) Trial. SU2C Genomics-Enabled Medicine for Melanoma (GEMM) Trial
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA522015
下载链接
链接失效反馈官方服务：
资源简介：
The goal of the GEMM Trial is to ascertain if comprehensive and systematic interrogation of a patient's tumor molecular profile improves outcomes compared to the current practice of physician's choice for metastatic melanoma patients who have progressed following first line therapy. The data shared here includes tumor/normal exome and tumor RNAseq data for the trial patients, as well as archival data for a subset of patients.
创建时间：
2019-02-12
